Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non-Current Deferred Tax Liability: 2013-2023

Historic Non-Current Deferred Tax Liability for Amphastar Pharmaceuticals (AMPH) over the last 9 years, with Sep 2023 value amounting to $201,000.

  • Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability fell 16.94% to $201,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $201,000, marking a year-over-year decrease of 16.94%. This contributed to the annual value of $144,000 for FY2022, which is 73.03% down from last year.
  • Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability amounted to $201,000 in Q3 2023, which was down 0.00% from $201,000 recorded in Q2 2023.
  • Amphastar Pharmaceuticals' 5-year Non-Current Deferred Tax Liability high stood at $2.9 million for Q3 2021, and its period low was $144,000 during Q4 2022.
  • Moreover, its 3-year median value for Non-Current Deferred Tax Liability was $364,000 (2022), whereas its average is $615,636.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first surged by 252.49% in 2021, then plummeted by 91.66% in 2022.
  • Over the past 5 years, Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability (Quarterly) stood at $867,000 in 2019, then decreased by 14.53% to $741,000 in 2020, then dropped by 27.94% to $534,000 in 2021, then tumbled by 73.03% to $144,000 in 2022, then decreased by 16.94% to $201,000 in 2023.
  • Its Non-Current Deferred Tax Liability was $201,000 in Q3 2023, compared to $201,000 in Q2 2023 and $178,000 in Q1 2023.